Drug Topics

JUNE 1, 2023

Years of steady price increases have made access to the essential medicine more difficult for millions of Americans with diabetes.

183

183

IDStewardship

JUNE 1, 2023

In this article the adoption of Firstline as a city-wide platform to support antimicrobial stewardship in collaboration with New York City Department of Health and Mental Hygiene is discussed. Interview with: William Greendyke, M.D. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 3 June 2023 We have come a long way since the term “ Antimicrobial Stewardship ” first appeared in the medical literature in 1996, brought to us by John McGowan and Dale Gerding.

Hospitals 131

Hospitals Nursing Homes Communication Medical Schools 131

Drug Topics

JUNE 1, 2023

A majority of patients say that taking cannabis helps them with chronic pain management and other conditions.

187

187

Pharmacy Times

JUNE 1, 2023

Pfizer Inc’s bivalent respiratory syncytial virus (RSV) vaccine Abrysvo is indicated to prevent lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

Vaccines 139

Vaccines FDA 139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

JUNE 1, 2023

The Centers for Medicare and Medicaid Services outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration | CMS outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs once the medications get full approval from the Food and Drug Administration.

FDA 145

FDA 145

STAT

JUNE 1, 2023

In a bold move, Coherus BioSciences plans to sell a biosimilar version of Humira — one of the world’s best-selling medicines — at a steep discount, and will work with Mark Cuban’s generic drug company to make the medicine available directly to consumers for even less. Specifically, the Coherus medicine will carry a $995 list price for a carton of two autoinjectors, an 85% discount from the $6,922 that AbbVie charges for Humira, which is used to treat rheumatoid arthri

Pharmaceutical Companies 144

Pharmaceutical Companies Pharmaceutical Companies 144

Fierce Healthcare

JUNE 1, 2023

A pair of new healthcare workforce surveys outline widespread reports of discrimination, racism and workplace violence perpetuated by patients and coworkers alike. | A pair of polls released this week detail the interpersonal difficulties nurses and other healthcare workers face in the workplace.

134

134

Pharmacy Times

JUNE 1, 2023

Investigators previously reported a statistically significant improvement in radiographic progression-free survival in the full intention-to-treat population of adults with deleterious or suspected deleterious BRCA-mutated metastatic castration-resistant prostate cancer.

FDA 123

FDA 123

Drug Topics

JUNE 1, 2023

Abrysvo is the second RSV vaccine approved by the FDA.

Vaccines 187

Vaccines FDA 187

Fierce Pharma

JUNE 1, 2023

After a panel of independent experts endorsed a narrow approval for AstraZeneca and Merck’s Lynparza in metastatic castration-resistant prostate cancer (mCRPC), the FDA has followed suit. | The drug is now approved to treat BRCA-mutated metastatic castration-resistant prostate cancer in combination with Johnson & Johnson’s Zytiga and a corticosteroid.

FDA 113

FDA 113

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

JUNE 1, 2023

Less than a month after CVS Health acquired Oak Street Health, the primary care provider plans to expand into four more states. | The company plans to open value-based primary care centers in Little Rock, Arkansas; Des Moines and Davenport, Iowa; Kansas City, Kansas and Richmond, Virginia, beginning this summer. Oak Street Health will operate centers in 25 states by the end of the year.

127

127

Pharmacy Times

JUNE 1, 2023

The primary medication therapies that can help with prophylaxis against HIV include pre-exposure prophylaxis and non-occupational post-exposure prophylaxis.

123

123

Fierce Pharma

JUNE 1, 2023

As doctors weigh various immunotherapy strategies for the treatment of early-stage non-small cell lung cancer, Merck & Co. | As doctors navigate the "messy" early-stage non-small cell lung cancer landscape with various immunotherapy approaches, Merck & Co. has now unveiled new data that it hopes can establish Keytruda, used before and after surgery, as a new standard of care.

117

117

STAT

JUNE 1, 2023

Tempus, a company that combines DNA sequencing for cancer with artificial intelligence, said Thursday that it is launching a voice-and-text assistant called Tempus One that will give physicians much easier access to patient data. The AI assistant is being launched ahead of the annual meeting of the American Society of Clinical Oncology in Chicago. Eric Lefkofsky, Tempus’ founder and CEO, told STAT Tempus will be rolling the product, called Tempus One, out to the 6,000 doctors that prescri

117

117

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

JUNE 1, 2023

About a month after GSK won the world's first approval for a respiratory syncytial virus (RSV) vaccine, rival Pfizer has followed suit. | After winning FDA approvals one month apart, Pfizer and GSK are set to launch competing RSV vaccines this fall.

Vaccines 109

Vaccines FDA 109

Fierce Healthcare

JUNE 1, 2023

Data breaches for the year have reached the high-water mark with the data of nearly 9 million individuals being compromised in a reported cyberattack on one of the country’s largest dental health i | Managed Care of North America posted a notice Friday that between Feb. 26 and March 7, a digital intruder stole the data of 8.9 million people. The cyberattack is the largest of its kind in 2023 to date.

111

111

Pharmacy Times

JUNE 1, 2023

As the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.

123

123

Fierce Pharma

JUNE 1, 2023

As Sandoz prepares to spin off from Novartis into its own generics and biosimilars business, the company has settled on a location for its new headquarters. | After spinning off from Novartis later this year, generics and biosimilars giant Sandoz plans to move into its new headquarters by the middle of 2024.

103

103

Fierce Healthcare

JUNE 1, 2023

For more than 24 hours, a hospital in Idaho has been diverting ambulances due to a cyberattack. | Idaho Falls Community Hospital along with adjacent Mountain View Hospital and local clinics are still recovering from a cyberattack that occurred earlier this week.

Hospitals 105

Hospitals 105

Drug Topics

JUNE 1, 2023

Individuals with type 1 diabetes (T1D) had brain atrophy patterns equivalent to a brain age about 6 years older than their actual age.

98

98

STAT

JUNE 1, 2023

Last Thursday, after 15 hours of deliberation, the Indiana State Licensing board ruled that our friend and colleague Caitlin Bernard, an OB-GYN, violated patient privacy laws in discussing the case of a 10-year-old girl who traveled from Ohio for an abortion. She was given a letter of reprimand and a $3,000 fine. While a relatively minor punishment, this finding should send a chill through the medical community and beyond.

103

103

Fierce Healthcare

JUNE 1, 2023

Georgia places troubled insurtech Friday Health Plans into receivership, forcing 40,000 patients to seek new coverage fdiamond Thu, 06/01/2023 - 13:04

111

111

STAT

JUNE 1, 2023

WASHINGTON — Researchers and health care advocates are warning that the debt ceiling deal would mean a harsh cut for science agencies like the National Institutes of Health. The debt ceiling deal hammered out by the White House and congressional leadership this weekend would freeze non-defense and veterans’ health spending at 2023 levels for next year and allow only a 1% bump in 2025.

103

103

Drug Topics

JUNE 1, 2023

Free medicine distribution was linked with a lower median total health care spending of $1641 per year over a 3-year period.

98

98

STAT

JUNE 1, 2023

The statistics are dismal, though they bear repeating: 81% of overdose deaths in the U.S. in 2021 involved an opioid. But as an addiction medicine specialist, there are figures that give me hope: one seminal study showed that 75% of patients who were given the FDA-approved medication buprenorphine to treat opioid use disorder daily for 12 months remained in recovery — compared with 0% who did not receive buprenorphine treatment for the entire 12 months.

FDA 100

FDA 100

Pharmacy Times

JUNE 1, 2023

Former and current smokers showed higher mortality from early-stage non-small cell lung cancer than never smokers.

120

120

STAT

JUNE 1, 2023

Having insurance coverage alone doesn’t guarantee that people can afford or would be willing to pay continuously for chronic disease medications like Ozempic, a new, large-scale study finds. Looking at insured patients with type 2 diabetes and heart failure, researchers found that people with higher prescription copayments were less likely to consistently take glucagon-like peptide-1 receptor agonists (GLP-1) and sodium-glucose cotransporter 2 inhibitors (SGLT2i) — two classes of d

Insurance 98

Insurance Insurance Coverage 98

Pharmaceutical Technology

JUNE 1, 2023

The UK’s National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending the use of Pfizer ’s rimegepant (Vydura) to prevent migraine attacks. The therapy has been recommended as an option to prevent episodic migraines in adult patients, who have between four and 15 migraine attacks per month, and where a minimum of three preventive treatments have previously failed.

98

98

STAT

JUNE 1, 2023

Microsoft-owned Nuance Communications sells its AI medical scribe platform to health care providers on a simple promise: If they shell out big bucks for the high-tech product, they can decrease doctor burnout and ultimately make more money by enabling doctors to see more patients. But executives at four health systems using the software, called DAX, told STAT that while the software might make it possible to see more patients, or justify higher charges to insurers for visits, the high price tag

Hospitals 98

Hospitals Insurance Communication 98

Hospital Pharmacy Europe

JUNE 1, 2023

Anti-diabetic drug lead to weight loss, providing a much needed impetus in the fight against the rising global obesity epidemic, but are these drugs the silver bullet? Rod Tucker investigates. According to recent data released by Boehringer Ingelheim and Zealand Pharma , their novel glucagon/GLP-1 receptor dual agonist, BI 456906, designed as an anti-diabetic medicine, gave rise to a 14.9% weight loss in those either obese or overweight compared with placebo.

Hospitals 98

Hospitals 98

STAT

JUNE 1, 2023

NEW YORK (AP) — Racial bias built into a common medical test for lung function is likely leading to fewer Black patients getting care for breathing problems, a study published Thursday suggests. As many as 40% more Black male patients in the study might have been diagnosed with breathing problems if current diagnosis-assisting computer software was changed, the study said.

98

98

Pharmaceutical Technology

JUNE 1, 2023

The US Food and Drug Administration (FDA) has granted a combination of AstraZeneca and MSD ’s Lynparza (olaparib), with standard therapies for treating BRCA-mutated (BRCAm) metastatic castration-resistant prostate cancer (mCRPC). On 31 May, the FDA granted approval based on subgroup analysis of the Phase III PROpel trial (NCT03732820) in patients with BRCA mutations.

FDA 97

FDA Chemotherapy 97

STAT

JUNE 1, 2023

Why are fake medical devices more lucrative than real ones? Is Ozempic a neurological treatment? And what’s at the cutting edge of oncology? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the shocking story of a medical device company that sold fake implants and the warped system that made the scam lucrative.

98

98

Pharmaceutical Technology

JUNE 1, 2023

A new intracellular drug delivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drug delivery technologies. The centre will be established by UK-based technology innovation centre CPI, in collaboration with Medicines Discovery Catapult, the University of Strathclyde, the University of Liverpool, and Imperial College London.

Vaccines 97

Vaccines 97